AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,289,243 | -15.1% | 1,545,016 | +0.0% | 0.76% | -4.4% |
Q2 2023 | $33,317,367 | -21.8% | 1,544,616 | +6.3% | 0.79% | -22.0% |
Q1 2023 | $42,625,621 | -6.2% | 1,452,816 | +18.1% | 1.02% | -7.0% |
Q4 2022 | $45,435,087 | +299.8% | 1,229,637 | +204.6% | 1.09% | +271.8% |
Q3 2022 | $11,365,000 | -39.4% | 403,737 | -58.6% | 0.29% | -46.2% |
Q2 2022 | $18,761,000 | +46.3% | 974,107 | -2.4% | 0.55% | +69.0% |
Q1 2022 | $12,828,000 | – | 998,307 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |